Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs AJANTA PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    IPCA LABS AJANTA PHARMA IPCA LABS/
AJANTA PHARMA
 
P/E (TTM) x 48.7 36.4 133.9% View Chart
P/BV x 5.1 7.9 64.1% View Chart
Dividend Yield % 0.3 0.3 104.1%  

Financials

 IPCA LABS   AJANTA PHARMA
EQUITY SHARE DATA
    IPCA LABS
Mar-23
AJANTA PHARMA
Mar-23
IPCA LABS/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,0621,426 74.5%   
Low Rs7681,062 72.3%   
Sales per share (Unadj.) Rs243.0297.2 81.7%  
Earnings per share (Unadj.) Rs19.446.7 41.5%  
Cash flow per share (Unadj.) Rs29.757.1 52.0%  
Dividends per share (Unadj.) Rs4.007.00 57.1%  
Avg Dividend yield %0.40.6 77.7%  
Book value per share (Unadj.) Rs230.3269.1 85.6%  
Shares outstanding (eoy) m253.70125.91 201.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.84.2 90.0%   
Avg P/E ratio x47.226.6 177.1%  
P/CF ratio (eoy) x30.821.8 141.4%  
Price / Book Value ratio x4.04.6 85.9%  
Dividend payout %20.615.0 137.6%   
Avg Mkt Cap Rs m232,120156,638 148.2%   
No. of employees `000NANA-   
Total wages/salary Rs m12,8767,851 164.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m61,64237,426 164.7%  
Other income Rs m1,518986 153.9%   
Total revenues Rs m63,16038,413 164.4%   
Gross profit Rs m9,0337,833 115.3%  
Depreciation Rs m2,6161,308 200.0%   
Interest Rs m48258 825.2%   
Profit before tax Rs m7,4537,453 100.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,5341,573 161.1%   
Profit after tax Rs m4,9195,880 83.7%  
Gross profit margin %14.720.9 70.0%  
Effective tax rate %34.021.1 161.1%   
Net profit margin %8.015.7 50.8%  
BALANCE SHEET DATA
Current assets Rs m51,89328,252 183.7%   
Current liabilities Rs m18,05811,393 158.5%   
Net working cap to sales %54.945.0 121.9%  
Current ratio x2.92.5 115.9%  
Inventory Days Days5166 77.8%  
Debtors Days Days610 56.8%  
Net fixed assets Rs m34,33618,707 183.6%   
Share capital Rs m254253 100.4%   
"Free" reserves Rs m58,16733,624 173.0%   
Net worth Rs m58,42033,877 172.5%   
Long term debt Rs m6,51813 52,142.4%   
Total assets Rs m86,22947,047 183.3%  
Interest coverage x16.5128.6 12.8%   
Debt to equity ratio x0.10 30,236.2%  
Sales to assets ratio x0.70.8 89.9%   
Return on assets %6.312.6 49.6%  
Return on equity %8.417.4 48.5%  
Return on capital %12.222.2 55.1%  
Exports to sales %42.959.9 71.6%   
Imports to sales %13.311.5 115.7%   
Exports (fob) Rs m26,43422,420 117.9%   
Imports (cif) Rs m8,1784,293 190.5%   
Fx inflow Rs m26,43422,420 117.9%   
Fx outflow Rs m8,1784,293 190.5%   
Net fx Rs m18,25718,127 100.7%   
CASH FLOW
From Operations Rs m8,0587,918 101.8%  
From Investments Rs m-7,250-5,596 129.6%  
From Financial Activity Rs m5,072-1,079 -470.2%  
Net Cashflow Rs m5,8811,243 473.1%  

Share Holding

Indian Promoters % 46.3 66.2 69.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 44.8 25.8 173.7%  
FIIs % 10.3 9.1 112.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 53.7 33.8 159.0%  
Shareholders   82,809 54,351 152.4%  
Pledged promoter(s) holding % 0.0 12.3 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare IPCA LABS With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on IPCA Labs vs AJANTA PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

IPCA Labs vs AJANTA PHARMA Share Price Performance

Period IPCA Labs AJANTA PHARMA S&P BSE HEALTHCARE
1-Day 0.11% 0.08% 0.88%
1-Month -4.98% -0.81% -4.09%
1-Year 49.28% 79.56% 59.00%
3-Year CAGR 7.72% 21.30% 18.97%
5-Year CAGR 21.22% 25.66% 19.20%

* Compound Annual Growth Rate

Here are more details on the IPCA Labs share price and the AJANTA PHARMA share price.

Moving on to shareholding structures...

The promoters of IPCA Labs hold a 46.3% stake in the company. In case of AJANTA PHARMA the stake stands at 66.2%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IPCA Labs and the shareholding pattern of AJANTA PHARMA.

Finally, a word on dividends...

In the most recent financial year, IPCA Labs paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 20.6%.

AJANTA PHARMA paid Rs 7.0, and its dividend payout ratio stood at 15.0%.

You may visit here to review the dividend history of IPCA Labs, and the dividend history of AJANTA PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Gift Nifty Down 79 Points | Why Adani Group Stocks are Falling | Baazar Style Retail Files for IPO | Top Buzzing Stocks Today Gift Nifty Down 79 Points | Why Adani Group Stocks are Falling | Baazar Style Retail Files for IPO | Top Buzzing Stocks Today(Pre-Open)

On Monday, Indian share markets reversed the trend as the session progressed and ended the day higher.